• Vor Bio to Participate in Upcoming Investor Conferences

    Source: Nasdaq GlobeNewswire / 01 Nov 2022 08:00:02   America/New_York

    CAMBRIDGE, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

    Credit Suisse 31st Annual Healthcare Conference
    A virtual presentation will be made live starting on Tuesday, November 8, 2022

    Stifel 2022 Healthcare Conference
    Fireside chat: Wednesday, November 16, 2022 at 10:20 am EST
    Location: Lotte New York Palace Hotel, New York, NY

    Jefferies London Healthcare Conference
    Fireside chat: Thursday, November 17, 2022 at 3:15 pm GMT (10:15 am EST)
    Location: The Waldorf Hilton, London, UK

    A live webcast and archived replay of the fireside chats along with a replay of the pre-recorded presentation will be available on the investors section of www.vorbio.com.

    About Vor Bio
    Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

    Contact:

    Media & Investors
    Sarah Spencer
    +1 857-242-6076
    sspencer@vorbio.com

     


    Primary Logo

Share on,